Utilizing neoadjuvant immunotherapies in patients with ER+, HER2- primary breast cancer

Utilizing neoadjuvant immunotherapies in patients with ER+, HER2- primary breast cancer

CheckMate 7FL: nivo vs PBO in high-risk ER+ HER2- BC with neoadjuvant chemo and adjuvant therapyПодробнее

CheckMate 7FL: nivo vs PBO in high-risk ER+ HER2- BC with neoadjuvant chemo and adjuvant therapy

Neoadjuvant Endocrine Therapy in Breast CancerПодробнее

Neoadjuvant Endocrine Therapy in Breast Cancer

Dr. Charles Perou | Distinguished Lectureship in Breast Cancer Research | SABCS 2022Подробнее

Dr. Charles Perou | Distinguished Lectureship in Breast Cancer Research | SABCS 2022

Neoadjuvant chemotherapy for breast cancer - Time to rethink. 27Jul22Подробнее

Neoadjuvant chemotherapy for breast cancer - Time to rethink. 27Jul22

ASCO Breast Cancer Update | Jane Meisel, MD | 2022 Review and Renew SedonaПодробнее

ASCO Breast Cancer Update | Jane Meisel, MD | 2022 Review and Renew Sedona

Optimizing Therapy in HER2+ Disease with Dr. Hope S. RugoПодробнее

Optimizing Therapy in HER2+ Disease with Dr. Hope S. Rugo

Adjuvant/Neoadjuvant Therapy for Breast Cancer: Updates and Molecular Predictors of BenefitПодробнее

Adjuvant/Neoadjuvant Therapy for Breast Cancer: Updates and Molecular Predictors of Benefit

Neoadjuvant Therapy for HER2-positive Breast Cancer - Dr. Scott ChristensenПодробнее

Neoadjuvant Therapy for HER2-positive Breast Cancer - Dr. Scott Christensen

Популярное